Jason Meyenburg

Jason Meyenburg currently works at Gemini Therapeutics Sub, Inc., as Chief Executive Officer & Director from 2019.
Mr. Meyenburg also formerly worked at Auregen Biotherapeutics SA, as Chief Executive Officer, Gemini Therapeutics, Inc., as President, Chief Executive Officer & Director, Alexion Pharmaceuticals, Inc., as Senior Vice President-Commercial Operations from 2003 to 2016, Sucampo Pharmaceuticals LLC, as Chief Commercial Officer from 2017 to 2018, Alexion Pharma GmbH, as Vice President-Commercial Operations from 2010 to 2014, Vtesse, Inc., as Chief Commercial Officer from 2016 to 2017, and Orchard Therapeutics Plc, as Chief Commercial Officer from 2018 to 2019.
Mr. Meyenburg received his undergraduate degree from the University of Maryland and Masters Business Admin degree from The Fuqua School of Business.